AKT1 and chronic myelogenous leukemia, BCR-ABL1 positive: Nevertheless, our findings, in contrast to the conventional RAGE-driven AKT activation, demonstrated that CML exposure actually restrained the activation of AKT and GSK3α/β in osteosarcoma cells (Figure 4E).